Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overv: Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overview and Forecast Analysis

Bronchopulmonary Dysplasia Treatment Market Forecast Key Players, Industry Overv Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies. The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period. The global bronchopulmonary dysplasia treatment market can be segmented based on drug type, therapy, end-user, and region. In terms of drug type, the market can be divided into bronchodilators, corticosteroids, diuretics, immunomodulators, and others. Based on therapy, the global bronchopulmonary dysplasia treatment market can be categorized into oxygen therapy, surfactant replacement therapy, mechanical ventilation, and others. The oxygen therapy segment is expected to hold a significant share of the global market during the forecast period due to factors such as effectiveness of drugs and more commonly used therapy. Based on end-user, the global bronchopulmonary dysplasia treatment market can be classified into hospitals, nursing homes, critical care units, and others. Request the Coronavirus Impact Analysis across Industries and Markets @   https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=33566